IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 199 filers reported holding IMMUNOGEN INC in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | -50.0% | 1,257 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $6,000 | 0.0% | 1,257 | +11.2% | 0.00% | 0.0% |
| Q3 2018 | $6,000 | -45.5% | 1,130 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $11,000 | -8.3% | 1,130 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | -14.3% | 1,130 | -49.3% | 0.00% | -20.0% |
| Q4 2017 | $14,000 | -58.8% | 2,230 | -49.0% | 0.01% | -61.5% |
| Q3 2017 | $34,000 | +9.7% | 4,370 | -0.5% | 0.01% | 0.0% |
| Q2 2017 | $31,000 | +72.2% | 4,391 | -3.1% | 0.01% | +62.5% |
| Q1 2017 | $18,000 | +80.0% | 4,530 | -3.6% | 0.01% | +60.0% |
| Q4 2016 | $10,000 | -16.7% | 4,700 | +4.1% | 0.01% | -16.7% |
| Q3 2016 | $12,000 | -20.0% | 4,513 | -2.1% | 0.01% | -14.3% |
| Q2 2016 | $15,000 | -61.5% | 4,612 | 0.0% | 0.01% | -63.2% |
| Q1 2016 | $39,000 | -32.8% | 4,612 | +7.2% | 0.02% | -26.9% |
| Q4 2015 | $58,000 | – | 4,304 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |